Advertisement
U.S. markets closed

Biosynex SA (0DL.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
4.8100-0.0400 (-0.82%)
At close: 08:32AM CET

Biosynex SA

22 Boulevard SEbastien Brant
Illkirch-Graffenstaden 67400
France
33 3 88 78 78 87
https://www.biosynex.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees551

Key Executives

NameTitlePayExercisedYear Born
Mr. Larry AbensurChairman & CEON/AN/AN/A
Dr. Thierry PaperDeputy CEO & Director126kN/AN/A
Mr. Thomas LamyDeputy CEO & DirectorN/AN/AN/A
Amounts are as of December 31, 2010 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.

Corporate Governance

Biosynex SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.